1. Home
  2. BSVN vs AURA Comparison

BSVN vs AURA Comparison

Compare BSVN & AURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bank7 Corp. Common stock

BSVN

Bank7 Corp. Common stock

HOLD

Current Price

$42.61

Market Cap

393.6M

Sector

Finance

ML Signal

HOLD

Logo Aura Biosciences Inc.

AURA

Aura Biosciences Inc.

HOLD

Current Price

$6.43

Market Cap

396.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BSVN
AURA
Founded
2004
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
393.6M
396.8M
IPO Year
2018
2021

Fundamental Metrics

Financial Performance
Metric
BSVN
AURA
Price
$42.61
$6.43
Analyst Decision
Buy
Strong Buy
Analyst Count
3
6
Target Price
$53.33
$20.33
AVG Volume (30 Days)
7.1K
197.8K
Earning Date
01-15-2026
11-13-2025
Dividend Yield
2.58%
N/A
EPS Growth
19.43
N/A
EPS
4.54
N/A
Revenue
$95,710,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$2.23
N/A
P/E Ratio
$9.21
N/A
Revenue Growth
11.45
N/A
52 Week Low
$32.49
$4.35
52 Week High
$50.26
$9.14

Technical Indicators

Market Signals
Indicator
BSVN
AURA
Relative Strength Index (RSI) 48.22 60.80
Support Level $41.21 $5.89
Resistance Level $43.13 $6.53
Average True Range (ATR) 0.88 0.33
MACD 0.23 0.10
Stochastic Oscillator 53.08 86.21

Price Performance

Historical Comparison
BSVN
AURA

About BSVN Bank7 Corp. Common stock

Bank7 Corp is a full-service commercial bank focused on providing customers with exceptional service and meeting their banking needs through a variety of commercial and retail financial services. It offers deposit banking products, including commercial deposit services, commercial checking, money market, and other deposit accounts, and retail deposit services such as certificates of deposit, money market accounts, checking accounts, negotiable order of withdrawal accounts, savings accounts, and automated teller machine access. etc. It generates revenues from interest income from financial instruments and non-interest income and service charges on deposit accounts.

About AURA Aura Biosciences Inc.

Aura Biosciences Inc is a clinical-stage biotechnology company developing precision immunotherapies to treat a range of solid tumors designed to preserve the function of organs afflicted with cancer. Its candidate bel-sar is in late-stage clinical development for the treatment of patients with primary choroidal melanoma, and other ocular oncology indications as well as in early-stage clinical development in bladder cancer. The Company views its operations and manages its business in one operating segment operating exclusively in the United States.

Share on Social Networks: